Lexis Nexis
 |  |  | 
Premier Destination for Sophisticated Buyers of Legal Services

Home > Search Legal Topics > Article Abstract



Another Federal District Court Rules That FDA Labeling Regulations Preempt Some State Law Tort Claims


by Gregory J. Wartman
Saul Ewing LLP
Philadelphia Office

February 9, 2009

Previously published on February 2008

A federal district court in Oklahoma recently ruled that a plaintiff's state law failure to warn claims against a prescription drug manufacturer are preempted by FDA regulations because FDA had considered and expressly rejected the plaintiff's proposed additional warning.


 

The views expressed in this article are solely the views of the author and not Martindale-Hubbell. This article is intended for informational purposes only and is not legal advice or a substitute for consultation with a licensed legal professional in a particular case or circumstance.


 

Practice Area Resource Centers
Visit our Practice Area Resource Centers to view practice area specific content compiled from a variety of legal sources. Find related articles, podcasts, industry leader insights and much more. We currently offer the following Practice Areas: Litigation; Intellectual Property; Real Estate; Corporate Law; Criminal Law; Bankruptcy; Immigration; Business Law; Insurance; Taxation





Total Practice Solutions

 
Terms & Conditions | Privacy | Copyright 2008 LexisNexis, a division of Reed Elsevier Inc. All rights reserved.